Sophocarpine Suppresses NF-κB-Mediated Inflammation Both In Vitro and In Vivo and Inhibits Diabetic Cardiomyopathy
Diabetic cardiomyopathy (DCM) is a leading cause of mortality in patients with diabetes. DCM is a leading cause of mortality in patients with diabetes. We used both in vitro and in vivo experiments to investigate the hypothesis that sophocarpine (SPC), a natural quinolizidine alkaloid derived from...
Main Authors: | Fang Zou, Ling Wang, Han Liu, Wei Wang, Longlong Hu, Xiaoying Xiong, Lijuan Wu, Yunfeng Shen, Renqiang Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01219/full |
Similar Items
-
Synthesis and biological evaluation of sophocarpinic acid derivatives as anti-HCV agents
by: Yinghong Li, et al.
Published: (2014-08-01) -
Inhibition of Sophocarpine on poly I:C/ D-GalN induced immunological liver injury in mice
by: Yinqiu Huang, et al.
Published: (2016-08-01) -
Cyclocarya paliurus ethanol leaf extracts protect against diabetic cardiomyopathy in db/db mice via regulating PI3K/Akt/NF-κB signaling
by: Yang Wang, et al.
Published: (2020-08-01) -
Suppression of NF-κB Activity: A Viral Immune Evasion Mechanism
by: Liyao Deng, et al.
Published: (2018-08-01) -
NF-κB and Its Regulators During Pregnancy
by: Fernando Gómez-Chávez, et al.
Published: (2021-05-01)